000			01656 a2200445 4500
005			20250515054903.0
264		0	_c20070321
008			200703s 0 0 eng d
022			_a1567-5769
024	7		_a10.1016/j.intimp.2006.10.011 _2doi
040			_aNLM _beng _cNLM
100	1		_aThejass, P
245	0	0	_aAntiangiogenic activity of Diallyl Sulfide (DAS). _h[electronic resource]
260			_bInternational immunopharmacology _cMar 2007
300			_a295-305 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAllyl Compounds _xpharmacology
650	0	4	_aAngiogenesis Inhibitors _xpharmacology
650	0	4	_aAnimals
650	0	4	_aCell Movement _xdrug effects
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aEndothelial Cells _xcytology
650	0	4	_aGranulocyte-Macrophage Colony-Stimulating Factor _xbiosynthesis
650	0	4	_aHumans
650	0	4	_aInterleukin-2 _xblood
650	0	4	_aInterleukin-6 _xbiosynthesis
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aNeovascularization, Physiologic _xdrug effects
650	0	4	_aRNA, Messenger _xanalysis
650	0	4	_aSulfides _xpharmacology
650	0	4	_aTissue Inhibitor of Metalloproteinase-1 _xblood
650	0	4	_aTumor Necrosis Factor-alpha _xbiosynthesis
650	0	4	_aVascular Endothelial Growth Factor A _xbiosynthesis
700	1		_aKuttan, Girija
773	0		_tInternational immunopharmacology _gvol. 7 _gno. 3 _gp. 295-305
856	4	0	_uhttps://doi.org/10.1016/j.intimp.2006.10.011 _zAvailable from publisher's website
999			_c16837513 _d16837513